Elsevier

Metabolism

Volume 62, Supplement 1, January 2013, Pages S20-S26
Metabolism

Lifetime experiences, the brain and personalized medicine: An integrative perspective

https://doi.org/10.1016/j.metabol.2012.08.020Get rights and content

Abstract

The aim of personalized medicine is to base medical prevention and therapy on the unique health and disease susceptibility profile of each individual. Starting from this idea, we briefly discuss the meaning of the word ‘personalized’ before analyzing the practical content of personalized healthcare. From a medical perspective, knowledge of a person encompasses both biological and biographical perspectives. The latter includes significant events and experiences throughout the person's lifespan, from conception to the present, in which epigenetic influences play an important role. In practice, we believe personalized medicine should emphasize the development and maintenance of a healthy nervous system. The neurobiological processes involved here depend heavily on the psychosocial environment, in particular the presence of responsible, caring adults and integration in a reasonably fair society. A healthy brain subsequently promotes good health throughout life, both through direct, favorable influences on the body's intrinsic biological pathways, and indirectly by enabling the person to engage in supportive relationships, make wise decisions and take good care of him/herself. From a public health perspective, we conclude that hi-tech personalized medicine based on detailed bio-molecular mapping, monitoring and tailored drug interventions holds promise only as part of a wider, socio-culturally informed approach to the person.

Introduction

The goal of ‘personalized medicine’ to base clinical decisions on the unique health profile of each individual is currently being fuelled by a rapidly increasing scientific insight into the enormous individual differences that exist among people, and a corresponding ambition to build this new knowledge into medical thought and practice for the benefit of patients and society [1]. Once one looks closer at the notion ‘personalized’ from a medical perspective, however, semantic uncertainties emerge. What types of individual differences are to be taken into consideration? Some definitions of personalized medicine are far more open-ended than others. Consider the following two definitions; (http://www.genomichealthcarestrategies.com/personalized_medicine.html):

The Nature glossary: “The use of genetic susceptibility or pharmacogenetic testing to tailor an individual's preventive care or drug therapy”; The Duke Institute for Genome Sciences & Policy, glossary: “The use of a person's clinical, genetic, genomic, and environmental information to select a medication, its dose, or to choose a therapy, or recommend preventive health measures.”

The difference between these two definitions contains more than one might think at first glance. The former is restricted to the individual's bio-molecular profile, while the latter opens for an unlimited range of “clinical and environmental” information and thereby also explicitly indicates that therapeutic/ preventative intervention can involve more than drug interventions. It is the contention of this article that personalized medicine (both for preventative and therapeutic purposes) should emphasize the fundamental, biomedical significance of a person's lifetime experiences, defined in a wide sense [2].

Section snippets

‘Personalized’ implies integrating biology and biography

By definition, knowing a person encompasses both naturalistic and humanistic perspectives [3]. Rather than personalized, the term individualized seems appropriate to denote the tailoring of medical interventions to match the patient's biological profile, including genetic and epigenetic traits. Individualized healthcare becomes personalized only when the clinician responsible for a particular patient has also familiarized her/himself with this patient's life-world (See BOX 1). In the following,

The molecular starting point: genes, environment and epigenetics

The term “epigenetics”, coined by Waddington [6], refers to characteristics of an organism acquired during differentiation and development. It refers to all influences on phenotype “above the genome”. A favorite model for visualizing such changes in gene expression was the “puffing” of genes in the polytene chromosomes of Drosophila salivary glands (see [7]). We now know that proteins play a key role, along with other factors, in the folding and unfolding of DNA and in DNA methyation. This

How humans adapt to challenges: the stress response

Protection and damage are two contrasting sides of the physiological systems involved in helping the human body adapt to the challenges of daily life, whether or not we call them “stressors”. Systems promoting adaptation include the hypothalamic–pituitary–adrenal (HPA) axis; the autonomic nervous system; the metabolic system (including the thyroid axis, insulin, other metabolic hormones); the gut; the kidneys; and the immune system (including the regulated network of cytokine producing cells

The keystone of prevention: growth and maintenance of a healthy brain

Human lifetime experiences have a profound impact on the brain, both as a target of stress and allostatic load/overload and as a determinant of physiological and behavioral response to stressors. The interaction of genes and experience shapes the architecture of the developing young brain, and the active agent is the “serve and return” nature of children's relationships with the important adults in a child's lives. (www.developingchild.harvard.edu) The mutual interrelatedness of brain and

Brain plasticity throughout the lifespan

It is important to understand that the human brain possesses a life-long and clinically significant capacity for reversible, structural plasticity. In the hippocampus and medial prefrontal cortex, chronic stress causes dendrites of neurons to shrink and become shorter and less branched, with an accompanying reduction in synaptic input [21]. This reduces the person's capabilities for nuanced cognitive function, memory and self-regulation. Glucocorticoids of the adrenal cortex and excitatory

Early life experiences become biologically inscribed

Animal models have taught us that prenatal stress of the mother can impair features of normal brain development [26] and that prolonged separation of infant from mother also impairs other aspects of brain development and function [27], [28], [29]. On the positive side, good maternal care and consistency of that care are powerful determinants of life-long patterns of reduced anxiety and efficient stress reactivity as well as social and cognitive development [30], [31], [32]. Moreover, there are

Social gradients and the biology of disadvantage

Beyond close relationships in childhood, the wider social and physical environment also has a fundamental impact on health. Studies on animals from rodents to infra-human primates have revealed widespread effects of social hierarchies on the brain, as well as on the stress responsive, immune [43] and cardiovascular systems, including the development of atherosclerosis where at least some of these effects are different between males and females [21].

Clear parallels exist in human society. The

From evidence to action: personalized prevention in real life

We currently find ourselves in an environment characterized by rapid advance in hi-tech knowledge about genomics, metabolomics and all the other -omics which pertain to the human organism. At the same time, the costs of conventional healthcare are soaring. It is therefore not surprising that a vision of personalized and preventive healthcare evokes huge interest, both among researchers, healthcare planners and investors. In relation to medical prevention, the aspirations go far beyond any

Closing remarks

The vision of a hi-tech personalized medicine, based on detailed bio-molecular mapping, monitoring and tailored drug interventions is profoundly fascinating and we believe it holds a certain promise. But in our opinion, this path is sustainable and responsible [51] only if seen as one element of a wider socially and culturally sensitive approach. Only then will personalized medicine do justice to the nature of human beings and hopefully be able to live up to expectations.

Biology and biography — the narrative side of personalized medicine

An authentic case history, presented with permission from the patient. Elina is a woman in her late 50s, working full-time at a teaching hospital. She comes to see her new primary care physician because of exhaustion and a painful right shoulder. Elina feels unable to work and says she needs a sickness certificate “for a week or so”. The doctor asks what is going on in her life, and Elina explains: During the preceding two weeks, she has lost both her parents. First her father passed away, and

References (51)

  • C.E. Wright et al.

    Subjective socioeconomic position, gender and cortisol responses to waking in an elderly population

    Psychoneuroendocrinology

    (2005)
  • M. Marmot

    Social determinants of health inequalities

    Lancet

    (2005)
  • J. Bousquet et al.

    Systems medicine and integrated care to combat chronic noncommunicable diseases

    Genome Medicine

    (2011)
  • A.L. Kirkengen

    The lived experience of violation: how abused children become unhealthy adults

    (2010)
  • A.M.J. Miles

    The care of the patient and the soul of the clinic: person-centered medicine as an emergent model of modern clinical practice

    Int J Person Centered Med

    (2011)
  • Getz L, Kirkengen AL, Ulvestad E. The human biology—saturated with experience....
  • B.S. McEwen et al.

    Critical biological pathways for chronic psychosocial stress and research opportunities to advance the consideration of stress in chemical risk assessment

    Am J Public Health

    (2011)
  • C.H. Waddington

    The epigenotype

    Endeavoour.

    (1942)
  • Z. Hochberg et al.

    Child health, developmental plasticity, and epigenetic programming

    Endocr Rev

    (2011)
  • R.L. Jirtle

    Randy L. Jirtle, PhD: epigenetics a window on gene dysregulation, disease. Interview by Bridget M. Kuehn

    JAMA

    (2008)
  • W.T. Boyce et al.

    Biological sensitivity to context: I. An evolutionary–developmental theory of the origins and functions of stress reactivity

    Dev Psychopathol

    (2005)
  • S.J. Suomi

    Risk, resilience, and gene × environment interactions in rhesus monkeys

    Ann N Y Acad Sci

    (2006)
  • B.S. McEwen et al.

    Stress- and allostasis-induced brain plasticity

    Annu Rev Med

    (2011)
  • T. Seeman et al.

    Socio-economic differentials in peripheral biology: cumulative allostatic load

    Ann NY Acad Sci.

    (2010)
  • P. Sterling et al.

    Allostasis: a new paradigm to explain arousal pathology

  • Cited by (70)

    • Medical knowledge integration and “systems medicine”: Needs, ambitions, limitations and options

      2019, Medical Hypotheses
      Citation Excerpt :

      Any cancer theory that does not reflect the influence of the microenvironment of cancer cells would be insufficient [116]. One of the most fruitful stimulus–response constructs in medicine has been Hans Selye’s concept of stress that helps to understand pathogenesis of most diseases on organismic, organ and cellular level [117,118]: mainly the organismic level as a conceptual framework that is important in the clinical context depicts the role of environmental stimuli and the adaptive reaction mode of the brain and its autonomous system, the endocrine system and the immune system [119]. In this context it is important to note that these three systems represent interconnected organismic subsystems that can operate in a stress mode, under acute and chronic conditions with different reactions such as homeostasis and adaptative allostasis [120,121].

    • Development of the concept of patient-centredness – A systematic review

      2019, Patient Education and Counseling
      Citation Excerpt :

      The concept of personalised medicine has a closely related name but a completely different meaning. Personalised medicine refers to using the patient’s unique genetic map or individual biomedical parameters to optimise biomedical treatment [26], and it could potentially be confused with patient-centredness. Patient-centredness was first mentioned by Enid Balint in 1969 [6].

    • Resilience of the brain and body

      2019, Stress: Physiology, Biochemistry, and Pathology Handbook of Stress Series, Volume 3
    View all citing articles on Scopus

    Publication of this article was supported by the Collège International de Recherche Servier (CIRS).

    View full text